“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection
复制标题
T1期结直肠癌内镜切除术后的“独立于病理学家”策略
DOI:
10.1007/s00535-022-01912-5
复制
发表时间:
2022
影响因子:
6.3
通讯作者:
Yeoh Khay Guan
中科院分区:
文献类型:
--
作者:
Ichimasa Katsuro;Kudo Shin-ei;Lee Jonathan Wei Jie;Yeoh Khay Guan
Widespread adoption of colorectal cancer (CRC) screening programs and advances in endoscopic treatments, such as endoscopic submucosal dissection and endoscopic fullthickness resection, have increased the opportunities to encounter early-stage CRC. Endoscopically treated submucosal invasive (T1) cancers may require additional bowel resection with lymph node dissection, depending on the risk of lymph node metastasis (LNM) determined by the following pathologic assessment: depth of submucosal invasion, lymphovascular invasion, differentiation, and tumor budding [1]. The current clinical management of T1 CRC presents two areas for improvement [2]: the limited diagnostic ability currently to predict LNM, and the diagnostic inconsistencies in histologic assessment of the four risk factors among pathologists. Due to the limited diagnostic ability to a priori determine LNM, current guidelines advocate intestinal resection with lymph node dissection for all T1 CRC with one or more risk factors, even despite the low rates of LNM (10%). To better the diagnostic ability of LNM among T1 CRC, several models predicting the presence of LNM using artificial intelligence based on clinicopathological information have been reported with varying degrees of accuracy [3]. All four of the aforementioned risk factors for LNM are pathological factors and are determined by pathologists. However, there has been fairly low agreement among pathologists in assessing lymphatic and vascular invasion in T1 CRCs, whereby the agreement among Japanese pathologists was j= 0.561 and j= 0.566, and j= 0.518 and j= 0.545 among American pathologists, and j= 0.543 and j= 0.560 among Europe pathologists, respectively [4]. Although the use of immunohistostaining has been reported to increase interobserver agreement in evaluating the presence of lymphatic or vascular invasion [5], there is currently no consensus for the use of immunohistostaining, such as D2-40 for lymphatic invasion or Victoria Blue/Elastica van Gieson for vascular invasion, whereby the conduct and practice of immunohistostaining practice vary significantly among pathologists. Furthermore, there was less agreement regarding the depth of submucosal invasion and tumor budding than for lymphatic or vascular invasion [6]. These issues need better solutions, such as to establish an objective and uniform treatment strategy. In this issue of Journal of Gastroenterology, Song et al. developed a prediction model analyzing hematoxylin and eosin (H&E)-stained whole slide images (WSIs) scanned at 9 20 magnification for LNM in T1 CRC using deeplearning without manual-pixel-level annotation [7]. Their model succeeded in overcoming the aforementioned two problems. Their study included 400 patients who underwent endoscopic resection with secondary surgical resection with lymph node dissection, and LNM-positivity accounted for 17.8%(71/400). The main outcome was the area under the receiver operating characteristic curve